Prevention of Disease, Disability, and Death by Infectious Diseases
Active
- Assistance listing
- 93.084
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 79 $462,422,346 in federal obligations
Program facts
- Assistance types
-
- Cooperative Agreement
- Project Grant
- Treasury account
-
- 75-0943-0-1-550
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) is issuing cooperative agreements and project grants under CFDA 93.084 to fund prevention of infectious disease, disability, and death through strengthened public health capacity, surveillance, laboratory capabilities, and disease control interventions, with the most recent award issued on September 1, 2026.
The program funds concrete infectious disease prevention and control activities spanning HIV treatment and prevention, sexually transmitted infections, vector-borne diseases, healthcare-associated infections, antimicrobial resistance, parasitic infections, rabies, fungal diseases, and travel-related illness. Recent awards exemplify this scope: a $1.2 million cooperative agreement to integrate postexposure prophylaxis packs into sexual health clinical care for gay and bisexual men and other men who have sex with men; a $6.1 million award supporting integrative care and healthy aging for adults with HIV; a $1.55 million award for enhanced surveillance and control of arboviruses in Puerto Rico; and multiple project grants supporting development of rapid diagnostic tests for hepatitis C virus and antimicrobial susceptibility testing for non-tuberculous mycobacterial infections. The program also funds regional centers of excellence for vector-borne disease control, pathogen genomics capacity-building, epidemiological and economic modeling, healthcare quality and safety infrastructure, and pre-travel health consultation networks.
The portfolio is dominated by cooperative agreements (85 percent of 79 awards) paired with a smaller share of project grants (15 percent). CDC is the sole funder across the program. Combined federal dollars obligated total $462.4 million. Award magnitudes range widely: the smallest recent project grants awarded roughly $12,700 to $614,000, while larger cooperative agreements span $1.2 million to $80.2 million for multi-year research platforms. Award cycles typically span 1 to 5 years with project periods of 1 to 5 years and annual budget periods; renewals at the end of project periods are made through new, competitive NOFOs.
Activity has been uneven in recent years, with 6 awards in 2022, 2 in 2023, 3 in 2024, 5 in 2025, and 1 through September 2026. Grant opportunities are currently open: RFA-CK-26-0107 (Building National Partnerships for Prevention of Emerging and Reemerging Infectious Diseases, due July 1, 2026); CDC-RFA-CK-26-0193 (Alpha-gal Syndrome awareness and surveillance, due July 9, 2026); CDC-RFA-CK-26-0221 (Parasitic infection prevention and control, due July 17, 2026); RFA-CK-26-035 and RFA-CK-26-036 (travel medicine research and pre-travel consultation networks, due November 5, 2026); and RFA-CK-27-106 (rabies detection and response, posted July 27, 2026). Eligibility typically spans state and local governments, higher education, nonprofits, tribal organizations, and in some cases for-profit entities and small businesses.
Objective and description
- Objective
The purpose of this program is to prevent disease, disability and death by infectious diseases. The specific objectives may include, but are not limited to: strengthening public health fundamentals; increasing capacity to prevent disease, disabilit
- Description
Prevention of Disease, Disability, and Death by Infectious Diseases
Eligibility
- Applicant eligibility
Dependent upon the individual NOFO, eligibility may range from open competition, limited competition, single-source, domestic and/or international in accordance with the authorizing legislation.
- Uses of assistance
Funds may be used in the prevention or control of disease, disability and/or death by infectious diseases. Restrictions to funding are designated in the individual Notice of Funding Opportunity (NOFO) and, for those awarded, in the Notice of Award (NoA).
- Length and time phasing of assistance
Financial assistance is available for 12-month budget period (s) within a 1- to 5-year project period. After awards are issued, funds are released in accordance with the payment procedure established by the grantee institution with Department of Health and Human Services (HHS).
How to apply
- Criteria for selecting proposals
Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
- Award procedure
Procedures are specified in the individual NOFOs.
- Time to approval or disapproval
As specified in the individual NOFOs.
- Renewals
Awards under this Program are typically issued for 1- to 5-year project periods. Renewals at the end of each project period are expected to be made available in a new/continuation NOFO with a complete application and review/award process as described in the NOFO. Annual renewals within an awarded multi-year project period are made via a non-competitive process and are subject to the availability of funds.
Grant opportunities
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Grant awards
Latest 10 of 79 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Massachusetts Department Of Public Health | $80,160,192 | 17% |
| 2 | Puerto Rico Science, Technology, And Research Trust | $66,163,081 | 14% |
| 3 | Department Of General Services Virginia | $49,346,472 | 11% |
| 4 | University Of Wisconsin System | $29,907,032 | 6% |
| 5 | Emory University | $21,030,402 | 5% |
| 6 | The General Hospital Corporation | $18,405,878 | 4% |
| 7 | Cornell University | $14,206,936 | 3% |
| 8 | Duke University | $12,079,448 | 3% |
| 9 | Rush University Medical Center | $10,303,448 | 2% |
| 10 | University Of Florida | $10,241,881 | 2% |
10 of 57 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $2,719,000 |
| FY2025 | $20,989,345 |
| FY2024 | $105,514,771 |
| FY2023 | $165,140,770 |
| FY2022 | $130,607,506 |
| FY2021 | $43,210,964 |
| FY2020 | $66,348,918 |
| FY2019 | $28,566,144 |
| FY2018 | $21,574,664 |
| FY2017 | $78,119,586 |
| FY2016 | $50,336,842 |
| FY2015 | $9,617,513 |
| FY2014 | $6,662,093 |
Show all 13
Quick answers
What is Assistance Listing 93.084?
Assistance Listing 93.084 is Prevention of Disease, Disability, and Death by Infectious Diseases, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Prevention of Disease, Disability, and Death by Infectious Diseases?
Its CFDA number is 93.084: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.084 awarded?
79 grant awards under 93.084 have obligated $462,422,346 in federal funds to 57 recipients.
Who receives the most funding from 93.084?
The recipients obligated the most under Prevention of Disease, Disability, and Death by Infectious Diseases are Massachusetts Department Of Public Health ($80,160,192), Puerto Rico Science, Technology, And Research Trust ($66,163,081) and Department Of General Services Virginia ($49,346,472).
How much did 93.084 obligate in fiscal year 2025?
Grants under 93.084 obligated $20,989,345 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.084?
5 of the latest 50 opportunities under 93.084 are open or forecasted. The latest, Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free Status, was posted on July 27, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program